Big Hunt On For A.I.D.S. Agent (Press, 13 October 1983)

As of October 1983, Acquired Immunodeficiency Syndrome (AIDS) has affected over 2000 individuals in the United States. Despite significant investments and efforts into AIDS research, scientists remain perplexed by the disorder's elusive causative agent. The first cases were acknowledged in 1981, contrasting sharply with the rapid identification of the bacterium responsible for Legionnaires’ disease in 1976. To identify a new disease's cause, researchers typically examine the symptoms, development, and incidence patterns. This process helps to suggest whether the agent is bacterial, viral, or fungal and guides scientists on where to look. Unlike Legionnaires' disease, which specifically impacted lung tissue, AIDS is known to be transmitted through blood and other bodily fluids and targets T-cells, integral to the immune system's function. Most researchers suspect AIDS is caused by a virus, specifically a variant that may share characteristics with known immune-suppressing viruses. One candidate for the AIDS agent is the human T-cell leukaemia-lymphoma virus (HTLV), which is associated with certain cancers and affects the same T-cells involved in AIDS. In laboratory settings, various screening methods can assist in identifying the type of infective agent involved. For instance, viruses are significantly smaller than bacteria, with the flu virus measuring only 0.08 microns across, which presents challenges in detection. Advanced techniques like electron microscopy can detect viral particles during replication, while specialised tests can identify particular classes of bacteria or viruses through the use of specific stains or growth media. To detect novel agents, especially those that have not been previously identified, scientists rely on a range of test methods, including the use of biological probes that react with known agents' molecular markers. However, if the target agent is entirely new, existing probes may fail to detect it. Researchers are hoping that AIDS may be a variant of an existing virus, allowing for some cross-recognition. One significant hurdle in AIDS research is that the virus compromises the immune defence, making patients susceptible to a variety of opportunistic infections, which complicates the identification process. This necessitates examining patients in the disease's early stages to differentiate the AIDS agent from other pathogens. Compounding these challenges is the nature of viruses, which are minuscule and may integrate their genetic material into the DNA of the cells they infect, making isolation and study difficult. To date, most tests aimed at identifying the AIDS agent have yielded inconclusive results, with antibody tests revealing some correlation to HTLV. About 30 percent of AIDS patient serum samples harbour antibodies to HTLV compared to only 5 percent in healthy individuals. Researchers are exploring various strategies to further investigate the AIDS agent, including examining atypical tissues from AIDS patients, using fluorescent markers to visualise unusual viruses, and attempting to develop an animal model for the disease. Scientists are hopeful that due to the rapid spread of AIDS, there will be ample patient samples to facilitate identification of the causative virus.

The text on this page is created, in the most part, using Generative AI and so may contain errors or omissions. It is supplied to you without guarantee or warranty of correctness. If you find an error or would like to make a content suggestion please get in contact

The text on this page is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 3.0 New Zealand